These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33790118)

  • 1. [High-throughput Screening Technology for Selective Inhibitors of Transporters and Its Application in Drug Discovery].
    Motoyaji T
    Yakugaku Zasshi; 2021; 141(4):511-515. PubMed ID: 33790118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology.
    Motoyaji T
    Chem Pharm Bull (Tokyo); 2020; 68(3):191-193. PubMed ID: 32115525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry-Based Screening for Drug Discovery.
    Winter M; Ries R; Kleiner C; Bischoff D; Luippold AH; Bretschneider T; Büttner FH
    SLAS Technol; 2019 Apr; 24(2):209-221. PubMed ID: 30074850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery.
    Simon RP; Häbe TT; Ries R; Winter M; Wang Y; Fernández-Montalván A; Bischoff D; Runge F; Reindl W; Luippold AH; Büttner FH
    SLAS Discov; 2021 Sep; 26(8):961-973. PubMed ID: 34308708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on ion channel transporters as a target for the drug discovery].
    Imaizumi Y; Kaneko S
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
    [No Abstract]   [Full Text] [Related]  

  • 6. MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High Throughput.
    Simon RP; Winter M; Kleiner C; Wehrle L; Karnath M; Ries R; Zeeb M; Schnapp G; Fiegen D; Häbe TT; Runge F; Bretschneider T; Luippold AH; Bischoff D; Reindl W; Büttner FH
    SLAS Discov; 2021 Jan; 26(1):44-57. PubMed ID: 33073664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice.
    Winter M; Simon RP; Häbe TT; Ries R; Wang Y; Kvaskoff D; Fernández-Montalván A; Luippold AH; Büttner FH; Reindl W
    SLAS Discov; 2023 Jul; 28(5):240-246. PubMed ID: 37031752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free high-throughput screening via mass spectrometry: a single cystathionine quantitative method for multiple applications.
    Holt TG; Choi BK; Geoghagen NS; Jensen KK; Luo Q; LaMarr WA; Makara GM; Malkowitz L; Ozbal CC; Xiong Y; Dufresne C; Luo MJ
    Assay Drug Dev Technol; 2009 Oct; 7(5):495-506. PubMed ID: 19715455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
    Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
    J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RapidFire BLAZE-Mode Is Boosting ESI-MS Toward High-Throughput-Screening.
    Bretschneider T; Ozbal C; Holstein M; Winter M; Buettner FH; Thamm S; Bischoff D; Luippold AH
    SLAS Technol; 2019 Aug; 24(4):386-393. PubMed ID: 30698995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.
    White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS
    Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System.
    Greenhough LA; Clarke G; Phillipou AN; Mazani F; Karamshi B; Rowe S; Rowland P; Messenger C; Haslam CP; Bingham RP; Craggs PD
    SLAS Discov; 2021 Jun; 26(5):663-675. PubMed ID: 33783261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technologies for transporter drug discovery.
    Weinglass AB; Garcia ML; Kaczorowski GL
    Channels (Austin); 2008; 2(5):312-21. PubMed ID: 18989100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in high-throughput mass spectrometry in drug discovery.
    Dueñas ME; Peltier-Heap RE; Leveridge M; Annan RS; Büttner FH; Trost M
    EMBO Mol Med; 2023 Jan; 15(1):e14850. PubMed ID: 36515561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.